Literature DB >> 33585339

COVID-19 in a Patient Newly Diagnosed with AIDS: Asymptomatic Disease.

Manuel Serrano Martins1, Fabiana Pimentel1, Wildemar Costa1, Claudia Fernandes2.   

Abstract

The COVID-19 pandemic has posed new challenges for the scientific community. The behaviour of the virus and outcomes in people living with HIV have not yet been properly studied. We report the case of a 34-year-old man with newly diagnosed HIV infection stage 4 and asymptomatic SARS-CoV-2 infection. Although immunocompromised patients are classified as being at high risk of developing severe COVID-19, HIV-related immunosuppression may have a protective role. LEARNING POINTS: It is important to remember that not every respiratory infection during this pandemic is due to SARS-CoV-2.We need more studies to elucidate the behaviour of COVID-19 in people living with HIV.There is still doubt about the best time for antiretroviral therapy (ART) initiation in this context. © EFIM 2021.

Entities:  

Keywords:  AIDS; COVID-19; HIV; SARS-CoV-2; immunosuppression

Year:  2021        PMID: 33585339      PMCID: PMC7875587          DOI: 10.12890/2021_002204

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  2 in total

Review 1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

2.  Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.

Authors:  Alexy Inciarte; Ana Gonzalez-Cordon; Jhon Rojas; Berta Torres; Elisa de Lazzari; Lorena de la Mora; Maria Martinez-Rebollar; Montserrat Laguno; Pilar Callau; Azucena Gonzalez-Navarro; Lorna Leal; Felipe Garcia; Josep Mallolas; Mar Mosquera; Maria A Marcos; Juan Ambrosioni; Josep M Miro; Esteban Martinez; Jose L Blanco
Journal:  AIDS       Date:  2020-10-01       Impact factor: 4.177

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.